Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Astrana Health Inc. - Common Stock (NQ:ASTH)

29.32 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Astrana Health Inc. - Common Stock

< Previous 1 2 3 Next >
2 Reasons to Like ASTH and 1 to Stay Skeptical
Over the last six months, Astrana Health’s shares have sunk to $29.02, producing a disappointing 14.8% loss - a stark contrast to the S&P 500’s 22.9% gain. This may have investors wondering how to... 
Via StockStory
Topics Government Stocks World Trade
1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 We Find Risky
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
1 Value Stock to Research Further and 2 We Find Risky
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
1 Volatile Stock on Our Watchlist and 2 We Ignore
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Winners And Losers Of Q2: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Healthcare Technology for Providers Stocks
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health... 
Via StockStory
Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
1 Surging Stock to Target This Week and 2 Facing Challenges
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
2 Healthcare Stocks on Our Watchlist and 1 We Avoid
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
3 Cash-Producing Stocks to Target This Week
Cash-generating companies often have the flexibility to invest, return capital to shareholders, or navigate downturns. The best of these businesses not only accumulate cash but deploy it strategically... 
Via StockStory
Integer Holdings, Astrana Health, Surgery Partners, IQVIA, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
1 Growth Stock to Add to Your Roster and 2 We Find Risky
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
Topics Economy
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy Initial Public Offering
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results
 
Via Benzinga
Topics Stocks
SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Topics Artificial Intelligence
Traders are paying attention to the gapping stocks in Friday's session.
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
Astrana Health (NASDAQ:ASTH) Posts Better-Than-Expected Sales In Q2, Stock Soars
Healthcare services company Astrana Health reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 34.7% year on year to $654.8 million. On top of that, next quarter’s... 
Via StockStory
Astrana Health Inc (NASDAQ:ASTH) Reports Mixed Q2 2025 Earnings with Revenue Beat but Significant EPS Miss
Astrana Health reports mixed Q2 2025 earnings with revenue beating estimates but EPS missing by 49%. Stock surges 10.4% in after-hours trading despite broader concerns. 
Via Chartmill
2 Stocks Under $50 for Long-Term Investors and 1 We Brush Off
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
1 Profitable Stock Worth Your Attention and 2 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
2 Oversold Stocks Set for a Comeback and 1 to Ignore
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
2 Healthcare Stocks with Competitive Advantages and 1 to Keep Off Your Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
1 Russell 2000 Stock on Our Watchlist and 2 to Keep Off Your Radar
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
Healthcare Technology for Providers Stocks Q1 Teardown: Astrana Health (NASDAQ:ASTH) Vs The Rest
Looking back on healthcare technology for providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Astrana Health (NASDAQ:ASTH) and its peers. 
Via StockStory
Healthcare Technology Stocks Q1 Recap: Benchmarking GoodRx (NASDAQ:GDRX)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at healthcare technology stocks, starting... 
Via StockStory
Reflecting On Healthcare Technology Stocks’ Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Tandem Diabetes (NASDAQ:TNDM) and its peers. 
Via StockStory
Astrana Health (ASTH): Buy, Sell, or Hold Post Q1 Earnings?
Astrana Health has gotten torched over the last six months - since November 2024, its stock price has dropped 39.1% to $25.63 per share. This was partly driven by its softer quarterly results and might... 
Via StockStory
Topics Government
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.